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Abstract
The introduction of deﬁned mutations into open reading frames (ORF) or non-
translated regions of the genome is important to study of the structure–function
relationship of amino acid residues in proteins or that of sequence motifs at the
genome level. We describe a simple two-step method for the introduction of deﬁned
single or multiple point mutations into the genome of Saccharomyces cerevisiae.
This method circumvents the need for plasmid-based mutagenesis and thus ensures
homogenous expression of the gene of interest within the cell population. It is based
on the introduction of a selectable marker downstream of the gene of interest. This
marker is then ampliﬁed with a gene-speciﬁc primer that harbours the desired point
mutation, creating a selectable marker-tagged mutant version of the gene of interest.
The mutant fragment is then integrated into the genome of a wild-type strain through
homologous recombination. Successive rounds of ampliﬁcation of the mutant loci with
primers that introduce additional point mutations upstream of existing mutations will
generate multiple deﬁned mutations within a single gene. As a proof of principle, we
have employed this method to generate a temperature-sensitive mutant version of the
plasma membrane ATPase, pma1-7, which bears two point mutations (Pro434Ala and
Gly789Ser). Phenotypic analysis of a pma1-7 haploid strain indicates that this allele
has the same characteristics as the original pma1-7 allele. It confers a temperature-
sensitive growth phenotype and the newly synthesized Pma1-7 protein is unstable and
rapidly degraded. Copyright © 2006 John Wiley & Sons, Ltd.
Keywords: site-directed mutagenesis; PCR; homologous recombination; plasma
membrane ATPase, yeast
Introduction
Site-directed mutagenesis is a powerful tool for
studying structure–function relationships in pro-
teins and DNA and to generate conditional alle-
les of essential genes. Traditionally, the method
is applied to alter single nucleotides in DNA that
has been cloned in a plasmid suitable for an
Escherichia coli-based mutagenesis system (Sam-
brook et al., 1989). The plasmid is then trans-
formed back into yeast to generate a strain that
carries the mutated version of the gene of interest
on a plasmid but lacks the corresponding wild-type
locus in the genome to assess the function of the
mutant allele.
To circumvent the need to ﬁrst clone the gene
of interest and subsequently select for the plasmid-
borne auxotrophic markers, it is desirable to per-
form nucleotide exchanges at the genomic level,
which is feasible in yeast due to the high efﬁciency
of homologous recombination. Genomic expres-
sion of the altered allele is desirable, as it ensures
deﬁned copy number and homogeneous expression
across the cell population and expression of the
protein at endogenous levels. Methods to trans-
fer alleles of a given gene from one strain back-
ground into another, or to directly modify the
sequence of a wild-type gene to generate a desired
point mutation, have previously been established
but are frequently complicated. For example, some
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of these protocols require a selectable phenotype
of the desired point mutation (Moerschell et al.,
1988; Rothstein, 1991), prior cloning of the gene
of interest into a specialized plasmid (Barton et al.,
1990; Scherer and Davis, 1979), require the use of
specialized plasmids for the multi-step generation
of a PCR-produced integration cassette (Erdeniz
et al., 1997; Langle-Rouault and Jacobs, 1995),
require long oligonucleotides (80–100 bp, e.g. for
the ‘delitto perfetto’ method; Storici et al., 2001),
or rely on the elimination of a selectable/counter-
selectable marker that had been inserted into the
gene of interest by direct repeat recombination,
which limits their use to genes that are non-
essential or to diploid cells (Gray et al., 2004,
2005; Szent-Gyorgyi, 1996).
To overcome some of these limitations, we
describe here a cloning-free PCR-based allele
replacement method that does not rely on the
use of a counter-selectable marker or specialized
plasmids and can be utilized to generate multiple
deﬁned mutations within the gene of interest, even
if the gene is essential. As a proof of principle,
we utilized the method to generate a temperature-
sensitive mutant allele of the plasma membrane
ATPase, PMA1, containing two point mutations.
We show that this allele of PMA1, pma1-7, has
the same phenotypic properties as the original
pma1-7 allele (Chang and Fink, 1995). It confers
a temperature-sensitive growth phenotype and the
mutant version of the protein is rapidly degraded
when synthesized at 37 ◦C.
Materials and methods
Yeast strains and growth conditions
Yeast strains used in this study are derived from
BY4741 or BY4742 (Winzeler et al., 1999) and
are listed in Table 1. Strains were cultivated in
YPD rich media [1% Bacto yeast extract, 2% Bacto
peptone (US Biological Swampscott, MA), 2%
glucose] or minimal media (Sherman et al., 1986).
Yeast was transformed by lithium acetate (Ito et al.,
1983).
Marker cassette-tagging and generation of a
pma1-7 allele
Tagging of the chromosomal locus of interest was
performed by homologous recombination using
the selectable marker gene from the template
pFA6a–His3MX6 (Longtine et al., 1998). The
marker gene was ampliﬁed by preparative PCR
with the gene-speciﬁc targeting primers listed in
Table 2.
Preparative PCR was performed in 3 × 100 μl
reactions each containing 1× reaction buffer (10
mM Tris–HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2
and 0.001% gelatin), 200 μM dNTPs, 1 μM each
primer, and 0.4 μl Taq DNA polymerase (Sigma
Chemical Co., St Louis, MO) and 0.4 μl High
Fidelity PCR Enzyme Mix (Fermentas, St. Leon-
Rot, Germany). Reactions were cycled 30 times at
94 ◦C for 1 min, 55 ◦C for 1 min and 65 ◦C for
2 min, with a ﬁnal extension step of 65 ◦C for
20 min. DNA from this PCR reaction was then
precipitated by ethanol and resuspended in 30 μl
water.
PCR fragment (3–5 μg) was used to transform
the BY4742 (RSY1533) haploid wild-type strain.
Correct integration of the marker cassette was
conﬁrmed by analytical colony PCR in a volume of
50 μl, using the same conditions as described above
for preparative PCR. Analytical PCR products were
precipitated with ethanol for subsequent restriction
analysis or directly separated on a 1% agarose
gel with a 100 bp ladder (Fermentas, St. Leon-
Rot, Germany). Genomic DNA was isolated as
described by Sherman et al. (1986) and used as
template for preparative PCR reaction to introduce
the desired point mutation.
Table 1. S. cerevisiae strains used in this study
Strain Relevant genotype Source or reference
YRS1533 BY4742; MATα his31 leu20 ura30 lys20 EUROSCARF: Winzeler (1999), #4157
YRS2784 BY4741; MATa his31 leu20 ura30 met150 EUROSCARF; Winzeler (1999), #4157
YRS2331 MATα; his31 leu20 lys20 ura30 PMA1::His3MX6 This study
YRS2783 MATa; his31 leu20 ura30 met150 LYS2 pma1-G789S::His3MX6 This study
YRS2779 MATα; his31 leu20 ura30 lys20 MET15 pma1-P434A,G789S::His3MX6 This study
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Table 2. Primers used in this study
Name Primer sequence (5′ –3′) Purpose
F1Pma1 cassette ATAATTTTTG TCACATTTTA ATCAACTTGA TTTTTCTGGT
cggatccccgggttaattaa
Forward primer for PMA1::His3KanMX6
cassette
R1Pma1GFP GATGAAATTT TAAGCAAACT CTAGTAGGAA ATAAGCGGCT
gaattcgagctcgtttaaac
Reverse primer for PMA1::His3KanMX6
cassette
Pma1G/A2365 AAGGGTGGTA TTATCCAAAA CTTCAGTGCT ATGAACGGTA
TTATGTTCTT GCAAATTTCC
Forward ﬁrst mutation
Pma1C/G1300 AGGCTTTCTT GAAGTCTTTG AAGCAATATG CAAAGGCTAA
GGACGCTTTG ACCAAGTACA
Forward second mutation
R1′Pma1 AAGGTGTGTG TGTGGATAAA ATATTAGAAT GACAATTCGA
GATGAAATTT TAAGCAAACT
Reverse ﬁrst and second mutation
Pma1-a TTGATTGTTT TCATCGCTAT Forward primer for PMA1::His3KanMX6
cassette control
His5contr-r TACGGGCGAC AGTCACATC Reverse primer for PMA1::His3KanMX6
cassette control
Pma1-e GTCGAAGGTG CTACTGATGC Forward ﬁrst mutation control
Pma1-frev TGGCTTACCG TTCATCAATC Reverse ﬁrst mutation control
Pma1-c GGTCTGGACT GCTTGTTTCT Forward second mutation control
Pma1-drev CAAGTGTCTA GCTTCGCTAA Reverse second mutation control
Sequences in upper case indicate homology to the genome of S. cerevisiae and those in lower case indicate homology to the PCR cassette
employed. Point mutations are indicated in bold and underlined.
The presence of the point mutation in candi-
date colonies was conﬁrmed by restriction fragment
length polymorphism (RFLP) and DNA sequenc-
ing. Sequencing of PCR fragments was performed
by Microsynth AG, Balgach, Switzerland.
Pulse-chase analysis of Pma1p
To determine the stability of newly synthesized
mutant forms of Pma1p, cells were pulsed with
radiolabelled amino acids for 5 min, chased for the
time points indicated, and Pma1p was immuno-
precipitated and analysed as described previously
(Gaigg et al., 2005).
Results and discussion
A simple method to generate genomic point
mutations
Although a number of methods to introduce point
mutations into the genome of S. cerevisiae have
been reported previously, none can be employed
without the use of dedicated reagents, such as
plasmids, selectable/counter-selectable markers, be
suitable for the introduction of multiple point
mutations, or would allow the isolation of point
mutations that do not confer a speciﬁc phenotype.
To overcome these limitations, we designed a
generally applicable method that does not require
special reagents or a scoreable phenotype for the
resulting point mutation.
The general strategy of the method is outlined
in Figure 1. It is based on a two-step introduction
of the desired point mutation. In a ﬁrst step, the
gene of interest is targeted in the 3′ untranslated
region (UTR) with a selectable marker, using
standard integration techniques, e.g. as applied to
the generation of gene deletions. In a second step,
the marker-tagged gene is ampliﬁed using a gene
internal primer that bears the desired mutation.
The PCR fragment bearing the mutant version
of the gene linked to the selectable marker is
then transformed into a wild-type strain. Through
homologous recombination, the mutant gene is
then inserted at the wild-type locus, resulting in
a replacement of the wild-type by the mutant
locus. Transformants are then ﬁrst screened for the
presence of the selectable marker at the correct
locus by colony PCR with a gene-speciﬁc primer.
Positive colonies are then further screened for
the presence of the point mutation, which may
be present or has been eliminated during the
recombination process. This last screen can be
performed in different ways, depending on the
precise nature of the desired mutation. For example
(a), if the resulting mutation confers a growth
phenotype it can directly be screened for. (b) In
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Figure 1.Outline of the mutagenesis strategy. To introduce
a deﬁned point mutation as indicated by the star (∗) into
the gene of interest that is delineated by the start and stop
codons, the gene is ﬁrst (1) targeted at the 3′ UTR with
a selectable marker; (2) genomic DNA from the resulting
strain is then PCR ampliﬁed with a forward primer bearing
the desired point mutation; (3) the resulting DNA fragment
is transformed into a wild-type strain, selecting for the
presence of the marker gene; (4) integration of the marker
gene at the desired locus is then conﬁrmed by colony PCR
and the presence of the point mutation is conﬁrmed by
phenotypic screening, RFLP analysis and DNA sequencing
some cases, the mutation generates or eliminates
a recognition site for an endonuclease, resulting
in a restriction fragment length polymorphism
(RFLP); in this case, a fragment covering the point
mutation can be ampliﬁed by PCR and scored
for the presence or absence of the restriction
site. In other cases (c), the point mutation may
affect an enzymatic activity that can be scored for.
Should none of these apply (d), the presence of the
desired mutation can directly be screened for by
DNA sequencing. Of 10 mutations that we have
successfully introduced using this procedure, nine
were scorable by RFLP analysis, indicating that
the generation or elimination of restriction enzyme
cleavage site can frequently be associated with a
given point mutation (Table 3).
Generating multiple genomic point mutations
Having conﬁrmed the presence of the desired point
mutation, an additional mutation can now been
introduced by using genomic DNA from the mutant
strain as a template for a PCR reaction with a
primer that introduces the second mutation 5′ to
the ﬁrst point mutation, as outlined in Figure 2.
Iteration of this procedure will thus allow the
introduction of additional mutations.
As a proof of principle, we generated a mutant
allele of the proton pumping plasma membrane
ATPase, Pma1p. This mutation, pma1-7, was gen-
erated by in vitro mutagenesis and plasmid shuf-
ﬂing (Chang and Fink, 1995). Cells carrying
the pma1-7 allele display a temperature-sensitive
growth phenotype and Pma1-7p affects the stability
and membrane raft association of the mutant pro-
tein (Bagnat et al., 2001; Chang and Fink, 1995).
pma1-7 bears two point mutations, a Pro → Ala
substitution in the catalytic domain at position
434 and a Gly → Ser exchange at position 789
in the cytoplasmic loop between transmembrane
Figure 2. Strategy to generate multiple mutations.
Additional point mutations can be introduced by reiteration
of the basic mutagenesis scheme. Starting from the ﬁrst
point mutation, which must lay closest to the 3′ UTR,
a second mutation is introduced by PCR ampliﬁcation of
genomic DNA isolated from this mutant and a primer
carrying the second point mutation. Transformation of the
resulting DNA fragment into a wild-type strain will then
generate the desired double mutant allele
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Table 3. Overview of point mutations that were generated
Name of the
cassette
Cassette
size (kb)
Transformation
rate (col/μg DNA)
RFLP
cleavage
Positive/
tested
Positive mutation/
total sequenced
PMA1::HIS5 1.48 2.5 — 2/6 —
PMA1P434A::HIS5 3.03 910 HpyCH4V 3/6 1/1
PMA1G789S::HIS5 1.91 205 TspRI 2/12 1/2
PMA1–7::HIS5 3.03 4.2 HpyCH4V/TspRI 3/8 3/3
PMA1K115R::HIS5 4.00 376 MseI 1/24 1/1
PMA1K781R::HIS5 2.00 19.2 StyI 1/10 1/1
SLC1::HIS5 1.48 22.5 — 5/10 —
SLC1Q44L::HIS5 2.38 1206 DdeI 6/30 2/6
YGR263::myc–HIS5 2.25 20 — 1/6 —
YGR263D328A::myc–HIS5 2.75 102 HhaI 2/12 1/2
YGR263S250A::myc–HIS5 3.05 259 HinfI 5/12 1/2
YGR263Y355H::myc–HIS5 2.68 1150 NlaIII 6/12 1/1
YGR263Y355F::myc–HIS5 2.68 1965 — — 2/4∗
Indicated is the gene name with the amino acid that was exchanged, the size of the PCR cassette that was used to transform wild-type cells,
the generation of a novel restriction site, the number of colonies that were positive by either RFPL or PCR analysis relative to the total number
of colonies that were tested, and the number of colonies that carried the desired point mutation compared to the number of colonies that
were sequenced. ∗ Determined by direct sequencing of candidate colonies.
segments 8 and 9 of Pma1p. These amino acid
exchanges correspond to a C → G transversion at
position 1300 of the PMA1 ORF and a G → A
transition at position 2365, respectively. We thus
ﬁrst tagged the wild-type PMA1 gene with the
His3MX6 selectable marker at the 3′ UTR (Long-
tine et al., 1998). Genomic DNA from the resulting
strain (RSY2331) was then isolated and used in a
PCR reaction with primer Pma1G/A2365, which
bears the desired G → A 2365 transition and a
downstream primer (R1′Pma1) that lies 3′ to the
selectable marker. The resulting fragment was then
transformed into BY4741 haploid wild-type strain.
The presence of the mutation was conﬁrmed by
colony PCR and DNA sequencing, resulting in a
strain carrying a pma1G789S mutation (YRS2783).
One of 12 tested transformants carried the desired
mutation, indicating that the procedure is reason-
ably efﬁcient.
To introduce the second point mutation 5′ to the
ﬁrst, genomic DNA from strain (YRS2783) was
employed as template for a PCR reaction with a
primer that now introduces the second mutation
(Pma1C/G1300). The fragment was again trans-
formed into a BY4742 haploid wild-type strain, and
the presence of the marker gene was scored for by
colony PCR. Positive colonies were then tested for
the presence of the two point mutations by DNA
sequencing, resulting in strain YRS2779. One of
four colonies tested carried the desired mutation,
again indicating that ﬁxation of the point mutation
is efﬁcient.
This ab initio generated allele of PMA1 showed
the phenotypic characteristics of the original
pma1-7 allele (Chang and Fink, 1995). Mutant
cells were temperature-sensitive for growth at
37 ◦C, and the mutant protein was unstable when
synthesized at 37 ◦C, as revealed by pulse-chase
analysis (Figure 3).
It should be noted that the presence of a point
mutation, particularly in an essential gene, may
confer a growth disadvantage or may even result
in lethality, making it difﬁcult or even impossi-
ble to isolate the desired mutation in a haploid
strain background. This problem can be overcome
by using either a haploid strain that carries an
additional copy of the gene of interest on a plas-
mid with a counter-selectable marker, or by using
a diploid strain to construct the desired allele.
Counter-selection against the plasmid or sporula-
tion of the diploid will then result in a haploid
strain with the desired mutation.
Although the point mutation in this method is
inevitably close to the 5′ end of the fragment
to be inserted, the efﬁcacy of genomic ﬁxation
of the mutation is high enough to render the
approach practical, which is consistent with reports
showing that the introduction of point mutation
is efﬁcient (average 24%) even when the point
mutation is close (within 25–50 bp) to the 5′ of the
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Figure 3.Generation of a temperature-sensitive allele of the plasmamembrane ATPase, pma1-7. A strain bearing the pma1-7
mutant allele was generated as described in the text and phenotypically characterized. (A) pma1-7 is temperature-sensitive
for growth. Wild-type (YRS1533) and pma1-7 mutant (YRS2779) strains were plated on minimal media and incubated at
either 24 ◦C or 37 ◦C. (B) Newly synthesized Pma1-7p is unstable. Wild-type and pma1-7 mutant strains were cultivated
in minimal media lacking methionine, cells were split and pre-incubated at either 24 ◦C or 37 ◦C for 15 min, pulse-labelled
by the addition of [35]S-methionine and [35]S-cysteine for 5 min and then chased by the addition of unlabelled amino
acids. Samples were taken at the time points indicated and Pma1p was immunoprecipitated and resolved by SDS–PAGE.
Quantiﬁcation of Pma1p levels is shown in the graph
homologous region that targets integration (Erdeniz
et al., 1997).
To circumvent a possible reduction of steady-
state levels of transcripts due to the insertion of the
selectable marker in the 3′ UTR of the gene, as has
recently been used to generate hypomorphic alleles
of essential genes (DAmP allele; Schuldiner et al.,
2005), loxP-ﬂanked selectable marker genes could
be used for marker targeting, in which case the
marker could be recycled after successful creation
of the desired point mutation, leaving the 3′ UTR
intact (Gueldener et al., 2002).
The procedure described here can easily be
employed to generate single or multiple deﬁned
mutations in the genome of S. cerevisiae, and thus
facilitates structure–function analysis of proteins
in vivo.
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